Cell adhesion molecules - can they be used to predict coronary artery disease in patients with familial

J E Paiker1, F J Raal, M Veller

  • 1Department of Chemical Pathology, South African Institute for Medical Research and University of the Witwatersrand, Johannesburg, South Africa. 158jan@chiron.wits.ac.za

Insights

Soluble cell adhesion molecules (CAMS) like VCAM, ICAM, and E-selectin do not predict atherosclerosis in familial hypercholesterolemia (FH) patients. Levels were not elevated and showed significant overlap with controls, limiting their use as biomarkers.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Biochemistry

Background:

  • Leukocyte adhesion via cell adhesion molecules (CAMS) is crucial in atherosclerosis initiation.
  • Familial hypercholesterolemia (FH) patients have a high risk of premature coronary artery disease (CAD).

Purpose of the Study:

  • To evaluate soluble VCAM, ICAM, and E-selectin as predictive markers for atherosclerosis presence and severity in FH patients.
  • To assess the diagnostic utility of these CAMS in distinguishing FH patients with and without CAD.

Main Methods:

  • Studied 20 heterozygous FH patients without CAD, 24 with CAD, 17 homozygous FH patients without CAD, 9 with CAD, and 50 controls.
  • Measured serum levels of soluble VCAM, ICAM, and E-selectin.
  • Assessed carotid artery intima-media thickness (IMT) in homozygous FH patients.

Main Results:

  • Soluble VCAM, ICAM, and E-selectin levels were not significantly elevated in FH patients (heterozygous or homozygous) compared to controls.
  • No significant difference in CAMS levels was observed between FH patients with and without CAD.
  • Wide variations and substantial overlap in CAMS levels between FH patients and controls were noted.

Conclusions:

  • Soluble VCAM, ICAM, and E-selectin are not effective predictive markers for atherosclerosis presence or severity in familial hypercholesterolemia.
  • Individual CAMS levels lack diagnostic value for assessing atherosclerosis in FH patients due to high variability and overlap with normal populations.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...